Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ALUNBRIG safely and effectively. See full prescribing information for ALUNBRIG. ALUNBRIG® (brigatinib) tablets, for oral use Initial U.S. Approval: 2017
Medication labelWhy this: Advisory · dailymed-prescription
ALUNBRIG is indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test [see Dosage and Administration (2.1)].
- generic_name
- brigatinib
- product_names
- brigatinib
- ndc
- 63020-113, 63020-090, 63020-180, 63020-198, 63020-113-30, 63020-090-30, 63020-090-07, 63020-180-30, 63020-198-30, 63020-180-23
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en